Author:
Huang Shi-tong,Tian Bi-shan,Xiao Ou,Yang Yong-juan,Zhou Shi-you
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference36 articles.
1. Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future;Kwong;Br J Clin Pharmacol,2014
2. Anterior segment uses of bevacizumab;Bahar;Curr Opin Ophthalmol,2012
3. Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis;Wang;PLoS One,2014
4. The effect of different doses of subconjunctival bevacizumab on the recurrence rate of excised primary pterygium;Razeghinejad;Bull Soc Belge Ophtalmol,2013
5. Subconjunctival bevacizumab for primary pterygium excision; a randomized clinical trial;Razeghinejad;J Ophthalmic Vis Res,2014
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献